Neutra(OTC) NTRR

Current Price$0.00

Market Cap$291.80K

Since IPO (2011)-100%

5 Year-97%

1 Year-67%

1 Month-33%

Neutra last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-24

Neutra stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-07-17
1 month	-33.33%	USD 0.00	2026-06-24
3 month	+0%	USD 0.00	2026-04-23
Year to date	+0%	USD 0.00	2025-12-31
1 year	-66.67%	USD 0.00	2025-07-24
3 year	-80%	USD 0.00	2023-07-25
5 year	-96.55%	USD 0.00	2021-07-23
Since inception	-100%	USD 1,300.00	2011-10-13

Neutra Financials at a Glance

Market Cap

$291.80K

Revenue (TTM)

$1.18M

Net Income (TTM)

$1.03M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-13.60 (Low)

Dividend

$0.00

Beta (Volatility)

-13.60 (Low)

Price

$0.00

Volume

3,180

Open

$0.00

Price

$0.00

Volume

3,180

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

-13.60 (Low)

Price

$0.00

Volume

3,180

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

NTRR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Neutra

Neutra Corp. is a biotechnology company focused on the research, development, and provision of hemp-derived nutraceuticals. Established in 2011 and headquartered in Sugar Land, Texas, the company offers a range of health and wellness products, including CBD-infused sports creams.

Products and Services

CBD-infused sports creams designed for athletes
Various health and wellness nutraceuticals
Research and development in hemp-derived products

Growth Outlook

Recent quarterly revenue increased to $352,811, showing strong demand
Gross profit margin improved to 80.24% in the latest quarter
Positive net income of $84,505 indicates operational efficiency

Financial Highlights

Trailing twelve months (TTM) revenue of $1,176,000 reflects growth potential
Operating income margin at 33.19% demonstrates effective cost management
Cash flow from operations reached $65,283 in the latest quarter

Neutra Corp. operates in a rapidly growing sector, capitalizing on the increasing consumer interest in hemp-derived products. The company's recent financial performance indicates a positive trajectory, with significant revenue growth and strong profit margins. The latest quarterly results highlight a robust operational framework, showcasing the ability to generate positive cash flow and net income. As the market for nutraceuticals continues to expand, Neutra Corp. is well-positioned to leverage its innovative product offerings and research capabilities to capture a larger share of this burgeoning industry.

AI Generated • Jul 21, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Sydney Jim

Website

www.neutrainc.com

Headquarters

Houston, TX 77478, US

NTRR Financials

Key Financial Metrics (TTM)

Gross Margin

76.27%

Operating Margin

93.92%

Net Income Margin

87.15%

Return on Equity

-124.55%

Return on Capital

N/A

Return on Assets

412.08%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$291.80K

Shares Outstanding

2.92B

Volume

3.18K

Avg. Volume

1.39M

Financials (TTM)

Gross Profit

$897.09K

Operating Income

$1.10M

EBITDA

$1.11M

Operating Cash Flow

$70.40K

Capital Expenditure

$3.12K

Free Cash Flow

$73.52K

Cash & ST Invst.

$49.91K

Total Debt

$115.20K

Neutra Performance Analysis

Neutra annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-01-31	USD 67,996	-26.1%
2024	2024-01-31	USD 39,534	-41.9%
2025	2025-01-31	USD 790,068	1898.5%
2026	2026-01-31	USD 1,023,508	29.5%

Neutra sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-07-31	35.7%
Q3	2025-10-31	29.6%
Q4	2026-01-31	-43.2%
Q1	2026-04-30	76.4%

Neutra annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-01-31	USD -0.00	-25.0%
2024	2024-01-31	USD -0.00	-66.7%
2025	2025-01-31	USD -0.00	0.0%
2026	2026-01-31	USD 0.00	N/A

Neutra sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-07-31	100.0%
Q3	2025-10-31	N/A
Q4	2026-01-31	-50.0%
Q1	2026-04-30	-100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2027YOY CHG

Revenue

$352.81K

+76.3%

Gross Profit

$283.10K

+561.9%

Gross Margin

80.24%

N/A

Market Cap

$291.80K

N/A

Market Cap/Employee

$19.45K

N/A

Employees

N/A

Net Income

$84.51K

+108.9%

EBITDA

$118.38K

+113.2%

Quarterly Fundamentals

Name

Q1 2027YOY CHG

Total Cash

$49.91K

-12.1%

Total Debt

$115.20K

-48.0%

Accounts Receivable

$105.10K

+405.6%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$115.20K

-48.0%

Return on Assets

4.12%

N/A

Return on Invested Capital

-6.26%

N/A

Free Cash Flow

$65.28K

+151.9%

Operating Cash Flow

$65.28K

+124.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BPTHBio-Path Holdings, Inc.

BPTHBio-Path Holdings, Inc.$0.04+0.00%

HXBMHelix BioMedix, Inc.

HXBMHelix BioMedix, Inc.$1.79+0.00%

HALBHalberd Corporation

HALBHalberd Corporation$0.00+11.11%

MRZMMarizyme, Inc.

MRZMMarizyme, Inc.$0.00+0.00%

CATV4Cable TV International, Inc.

CATV4Cable TV International, Inc.$0.00+0.00%

EMMAEmmaus Life Sciences, Inc.

EMMAEmmaus Life Sciences, Inc.$0.01+0.00%

ORGSOrgenesis Inc.

ORGSOrgenesis Inc.$0.40+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.46-0.01%

TAT&T

TAT&T$24.13+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

Questions About NTRR

What is the current price of Neutra?

Neutra is trading at $0.00 per share.

What is the 52-week range for Neutra?

Over the past 52 weeks, Neutra has traded between $0.00 and $0.00.

How much debt does Neutra have?

As of the most recent reporting period, Neutra reported total debt of $115.20K.

How much cash does Neutra have on hand?

Neutra reported $49.91K in cash and cash equivalents in its most recent financial results.

What is Neutra’s dividend yield?

Neutra does not currently have a dividend yield.

Neutra(OTC) NTRR

Neutra Financials at a Glance

NTRR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Neutra

NTRR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Neutra Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NTRR

What is the current price of Neutra?

What is the 52-week range for Neutra?

How much debt does Neutra have?

How much cash does Neutra have on hand?

What is Neutra’s dividend yield?

Premium Investing Services